Argentina | Spanish
Australia | English
Austria | German
Belgium | English
Belgium | Flemish
Belgium | French
Bermuda | English
Brazil | Portuguese
Canada | English
Canada | French
Chile | Spanish
China | Chinese
Colombia | Spanish
Croatia | Croatian
Croatia | English
Czech Republic | English
Denmark | Danish
Egypt | English
Finland | Finnish
France | French
Georgia | Georgian
Germany | German
Greece | Greek
Hong-Kong | English
India | English
Indonesia | English
Ireland | English
Italy | Italian
Japan | Japanese
Jordan | English
Korea | Korean
Kuwait | English
Lebanon | English
Lebanon | French
Luxembourg | French
Malaysia | English
Mexico | Spanish
Netherlands | Dutch
New Zealand | English
Philippines | English
Poland | Polish
Portugal | Portuguese
Romania | Romanian
Russia | Russian
Serbia | Serbian
Singapore | English
South Africa | English
Spain | Spanish
Sweden | English
Switzerland | English
Switzerland | French
Switzerland | German
Taiwan | Traditional Chinese
Thailand | English
Turkey | Turkish
Ukraine | Ukrainian
UAE | English
United Kingdom | English
United States | English
Vietnam | English
Hemant Patel, head of the Bio/Pharma/Life Sciences team in the executive compensation practice, discusses how a pre-commercial, biotech company that recently completed an IPO, used our Guiding Principles to add more flexibility to its pay philosophy. Biotech companies are extremely volatile, and we are able to help our clients navigate that difficult terrain.